Which companies overlap with Zhejiang Provincial Center for Disease Control and Prevention's portfolio?

Top competitors by shared drug class: Sanofi Pasteur, a Sanofi Company, Sinovac Biotech Co., Ltd, Pfizer, Jiangsu Province Centers for Disease Control and Prevention, China National Biotec Group Company Limited.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/zhejiang-provincial-center-for-disease-control-and-prevention.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Zhejiang Provincial Center for Disease Control and Prevention — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Zhejiang Provincial Center for Disease Control and Prevention pipeline: 13 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

13 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
EV71	EV71	marketed			Other
SIV	SIV	marketed			Virology/Research
Sabin IPV + Sabin IPV + Sabin IPV	Sabin IPV + Sabin IPV + Sabin IPV	marketed	inactivated viral vaccine	poliovirus serotypes 1, 2, and 3	Immunology / Infectious Disease
HPV（0d），HPV（6m），MMR（7m）	HPV（0d），HPV（6m），MMR（7m）	marketed
vaccinate with DT	vaccinate with DT	marketed	Vaccine		Immunology / Infectious Disease Prevention
MMR（0d），HPV（1m），HPV（7m）	MMR（0d），HPV（1m），HPV（7m）	marketed	vaccine		Immunology / Infectious Disease
vaccinate with DTaP	vaccinate with DTaP	marketed	vaccine		Immunology
vaccinated with Sabin IPV	vaccinated with Sabin IPV	marketed	vaccine	poliovirus serotypes 1, 2, and 3	Immunology
Sabin IPV+ bOPV+ bOPV	Sabin IPV+ bOPV+ bOPV	marketed	vaccine		Immunology / Infectious Disease
Sabin IPV + Sabin IPV + bOPV	Sabin IPV + Sabin IPV + bOPV	marketed	vaccine		Immunology / Infectious Disease
vaccinated with bOPV	vaccinated with bOPV	marketed	vaccine		Immunology
HPV+MMR（0d），HPV（6m）	HPV+MMR（0d），HPV（6m）	marketed	vaccine		Immunology

Therapeutic area mix

Immunology / Infectious Disease · 5
Immunology · 4
Immunology / Infectious Disease Prevention · 1
Other · 1
Virology/Research · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Sanofi Pasteur, a Sanofi Company · 4 shared drug classes
Sinovac Biotech Co., Ltd · 4 shared drug classes
Pfizer · 3 shared drug classes
Jiangsu Province Centers for Disease Control and Prevention · 3 shared drug classes
China National Biotec Group Company Limited · 3 shared drug classes
Centers for Disease Control and Prevention · 3 shared drug classes
Boryung Pharmaceutical Co., Ltd · 3 shared drug classes
GlaxoSmithKline · 3 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Zhejiang Provincial Center for Disease Control and Prevention:

Cite this brief

Drug Landscape (2026). Zhejiang Provincial Center for Disease Control and Prevention — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/zhejiang-provincial-center-for-disease-control-and-prevention. Accessed 2026-05-17.